United States Biotechnology & Medical Research

Perspective Therapeutics Inc (CATX)

Track

Ticker: CATX Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Perspective Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.7
Hunt Jonathan Robert Chief Accounting Officer Officer
Transaction date
Purchase
Price
110.02
Quantity 93,127 -21.0%
Value US$778,718
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
454.96
Quantity 41,085 -27.5%
Value US$1,246,102
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
434.72
Quantity 73,820 -18.0%
Value US$62,705
4.0
Woods Lori A Non-Executive Director
Transaction date
Purchase
Price
2.13
Quantity 23,475 +14.7%
Value US$49,999
3.6
Spoor Johan M. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.21
Quantity 4,650 +inf%
Value US$10,288
3.6
Spoor Johan M. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
2.24
Quantity 22,026 +59.0%
Value US$49,384
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
2.27
Quantity 22,192 +45.6%
Value US$50,376
3.9
Graham Juan Chief Financial Officer Officer
Transaction date
Purchase
Price
2.25
Quantity 33,333 +1649.3%
Value US$74,946
0.6
HENSON HEIDI Non-Executive Director
Transaction date
Purchase
Price
3.85
Quantity 25,975 +inf%
Value US$100,004
3.6
Spoor Johan M. CEO Executive Director
Transaction date
Purchase
Price
3.77
Quantity 8,000 +28.3%
Value US$30,132
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
3.67
Quantity 2,619 +0.6%
Value US$9,612
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
3.62
Quantity 3,647 +0.9%
Value US$13,202
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
3.88
Quantity 10,000 +25.8%
Value US$38,800
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
3.60
Quantity 2,400 +6.6%
Value US$8,640
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
3.94
Quantity 29 +0.1%
Value US$114
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
3.55
Quantity 400 +1.1%
Value US$1,420
3.6
Spoor Johan M. CEO Executive Director
Transaction date
Purchase
Price
3.80
Quantity 6,600 +11.0%
Value US$25,080
3.6
Spoor Johan M. CEO Executive Director
Transaction date
Purchase
Price
3.80
Quantity 5,400 +inf%
Value US$20,520
3.6
Spoor Johan M. CEO Executive Director
Transaction date
Purchase
Price
3.78
Quantity 14,500 +10.5%
Value US$54,868
3.4
Mark Austin affiliate
Transaction date
Proposed sale
Price
15.80
Quantity 2,500
Value US$39,500
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
9.82
Quantity 1,800 +5.3%
Value US$17,667
4.0
Woods Lori A Non-Executive Director
Transaction date
Purchase
Price
10.80
Quantity 83 +0.1%
Value US$896
4.0
Woods Lori A Non-Executive Director
Transaction date
Purchase
Price
10.90
Quantity 4,504 +2.9%
Value US$49,094
3.6
Spoor Johan M. CEO Executive Director
Transaction date
Purchase
Price
1.17
Quantity 100,000 +266.2%
Value US$117,430
4.0
Woods Lori A Non-Executive Director
Transaction date
Purchase
Price
1.46
Quantity 34,246 +2.3%
Value US$49,992
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
1.38
Quantity 55,000 +14.9%
Value US$75,900
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
1.40
Quantity 12,000 +3.6%
Value US$16,800
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
1.40
Quantity 13,006 +4.1%
Value US$18,207
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
1.34
Quantity 18,656 +5.3%
Value US$24,999
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
1.32
Quantity 11,375 +3.4%
Value US$15,015
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.70
Quantity 3,500 +1.0%
Value US$2,450
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.72
Quantity 42,879 +14.7%
Value US$30,873
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.71
Quantity 57,121 +24.3%
Value US$40,556
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.71
Quantity 5,127 +2.2%
Value US$3,640
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.71
Quantity 18,579 +8.8%
Value US$13,191
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.64
Quantity 21,235 +11.2%
Value US$13,590
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.64
Quantity 4,031 +2.2%
Value US$2,580
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.54
Quantity 50,000 +36.7%
Value US$27,000
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.55
Quantity 25,000 +22.5%
Value US$13,750
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.59
Quantity 8,513 +8.3%
Value US$5,023
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.61
Quantity 14,850 +16.9%
Value US$9,058
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.61
Quantity 12,250 +16.2%
Value US$7,472
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.49
Quantity 22,134 +41.3%
Value US$10,846
3.8
Puhlmann Markus Chief Medical Officer Officer
Transaction date
Purchase
Price
0.50
Quantity 280,000 +25.6%
Value US$139,888
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.49
Quantity 29,862 +126.1%
Value US$14,632
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.33
Quantity 3,663 +inf%
Value US$1,203
3.8
Puhlmann Markus Chief Medical Officer Officer
Transaction date
Purchase
Price
0.34
Quantity 400,000 +57.5%
Value US$137,000
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.32
Quantity 13,680 +136.8%
Value US$4,378
3.8
Puhlmann Markus Chief Medical Officer Officer
Transaction date
Purchase
Price
0.26
Quantity 60,419 +9.5%
Value US$15,461
4.1
Williamson Robert F III Non-Executive Director
Transaction date
Purchase
Price
0.26
Quantity 10,000 +inf%
Value US$2,600
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
0.26
Quantity 125,000 +65.2%
Value US$32,338
3.8
Puhlmann Markus Chief Medical Officer Officer
Transaction date
Purchase
Price
0.27
Quantity 135,006 +27.0%
Value US$36,276
4.0
Woods Lori A Non-Executive Director
Transaction date
Purchase
Price
0.27
Quantity 152,962 +11.2%
Value US$41,284
4.0
Woods Lori A Non-Executive Director
Transaction date
Purchase
Price
0.27
Quantity 32,238 +2.4%
Value US$8,704
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
0.38
Quantity 32,200 +20.2%
Value US$12,236
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
0.38
Quantity 53,204 +50.0%
Value US$20,265
4.0
Woods Lori A CEO Executive Director
Transaction date
Purchase
Price
0.34
Quantity 100,000 +9.6%
Value US$33,540
3.4
Austin Mark John VP Finance/Prin Fin&Acct Offic Officer
Transaction date
Purchase
Price
0.29
Quantity 13,800 +34.3%
Value US$3,959
3.4
Austin Mark John VP Finance/Prin Fin&Acct Offic Officer
Transaction date
Purchase
Price
0.29
Quantity 5,000 +14.2%
Value US$1,425
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
0.29
Quantity 25,675 +31.8%
Value US$7,443
4.0
Woods Lori A CEO Executive Director
Transaction date
Purchase
Price
0.30
Quantity 75,000 +7.7%
Value US$22,230
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
0.28
Quantity 13,325 +19.8%
Value US$3,718
4.0
Woods Lori A CEO Executive Director
Transaction date
Purchase
Price
0.38
Quantity 68,000 +12.5%
Value US$25,534
3.7
Hunt Jonathan Robert Chief Financial Officer Officer
Transaction date
Purchase
Price
0.52
Quantity 67,306 +inf%
Value US$34,999
McCormick Michael W Non-Executive Director
Transaction date
Purchase
Price
0.52
Quantity 19,230 +87.4%
Value US$10,000
4.0
Woods Lori A CEO Executive Director
Transaction date
Purchase
Price
0.52
Quantity 48,076 +inf%
Value US$25,000
Cavanagh William Chief R&D Officer Officer
Transaction date
Purchase
Price
0.52
Quantity 7,692 +38.5%
Value US$4,000
Hoffmann Alan Non-Executive Director
Transaction date
Purchase
Price
0.52
Quantity 19,230 +inf%
Value US$10,000
3.4
Austin Mark John Controller/Prin Fin&Acct Offic Officer
Transaction date
Purchase
Price
0.52
Quantity 19,230 +120.2%
Value US$10,000
Vitale Philip J Non-Executive Director
Transaction date
Purchase
Price
0.52
Quantity 20,000 +18.2%
Value US$10,400
Krachon Michael EVP of Sales & Marketing Officer
Transaction date
Purchase
Price
0.52
Quantity 28,844 +52.4%
Value US$14,999
Krachon Michael VP of Sales & Marketing Officer
Transaction date
Purchase
Price
0.39
Quantity 50,000 +inf%
Value US$19,495
Cavanagh William Chief R&D Officer Officer
Transaction date
Purchase
Price
0.39
Quantity 10,000 +100.0%
Value US$3,900
Woods Lori A CEO Executive Director
Transaction date
Purchase
Price
0.39
Quantity 25,000 +9.8%
Value US$9,745
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-17 2025-11-13 B Purchase
3.7
Hunt Jonathan Robert

Chief Accounting Officer

Officer
93,127 -21.0%
110.02
US$778,718 		93,127 -21.0% 110.02 US$778,718
2025-11-14 2025-11-12 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
41,085 -27.5%
454.96
US$1,246,102 		41,085 -27.5% 454.96 US$1,246,102
2025-04-01 2025-03-31 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
73,820 -18.0%
434.72
US$62,705 		73,820 -18.0% 434.72 US$62,705
2025-04-01 2025-03-31 B Purchase
4.0
Woods Lori A
Non-Executive Director
23,475 +14.7%
2.13
US$49,999 		23,475 +14.7% 2.13 US$49,999
2025-04-01 2025-03-28 B Purchase
3.6
Spoor Johan M.

Chief Executive Officer

Executive Director
4,650 +inf%
2.21
US$10,288 		4,650 +inf% 2.21 US$10,288
2025-04-01 2025-03-28 B Purchase
3.6
Spoor Johan M.

Chief Executive Officer

Executive Director
22,026 +59.0%
2.24
US$49,384 		22,026 +59.0% 2.24 US$49,384
2025-04-01 2025-03-28 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
22,192 +45.6%
2.27
US$50,376 		22,192 +45.6% 2.27 US$50,376
2025-04-01 2025-03-28 B Purchase
3.9
Graham Juan

Chief Financial Officer

Officer
33,333 +1649.3%
2.25
US$74,946 		33,333 +1649.3% 2.25 US$74,946
2024-12-06 2024-12-04 B Purchase
0.6
HENSON HEIDI
Non-Executive Director
25,975 +inf%
3.85
US$100,004 		25,975 +inf% 3.85 US$100,004
2024-12-04 2024-12-04 B Purchase
3.6
Spoor Johan M.

CEO

Executive Director
8,000 +28.3%
3.77
US$30,132 		8,000 +28.3% 3.77 US$30,132
2024-11-27 2024-11-25 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
2,619 +0.6%
3.67
US$9,612 		2,619 +0.6% 3.67 US$9,612
2024-11-27 2024-11-25 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
3,647 +0.9%
3.62
US$13,202 		3,647 +0.9% 3.62 US$13,202
2024-11-27 2024-11-25 B Purchase
3.7
Hunt Jonathan Robert

Chief Financial Officer

Officer
10,000 +25.8%
3.88
US$38,800 		10,000 +25.8% 3.88 US$38,800
2024-11-27 2024-11-25 B Purchase
3.7
Hunt Jonathan Robert

Chief Financial Officer

Officer
2,400 +6.6%
3.60
US$8,640 		2,400 +6.6% 3.60 US$8,640
2024-11-27 2024-11-25 B Purchase
3.7
Hunt Jonathan Robert

Chief Financial Officer

Officer
29 +0.1%
3.94
US$114 		29 +0.1% 3.94 US$114
2024-11-27 2024-11-25 B Purchase
3.7
Hunt Jonathan Robert

Chief Financial Officer

Officer
400 +1.1%
3.55
US$1,420 		400 +1.1% 3.55 US$1,420
2024-11-26 2024-11-25 B Purchase
3.6
Spoor Johan M.

CEO

Executive Director
6,600 +11.0%
3.80
US$25,080 		6,600 +11.0% 3.80 US$25,080
2024-11-26 2024-11-25 B Purchase
3.6
Spoor Johan M.

CEO

Executive Director
5,400 +inf%
3.80
US$20,520 		5,400 +inf% 3.80 US$20,520
2024-11-26 2024-11-25 B Purchase
3.6
Spoor Johan M.

CEO

Executive Director
14,500 +10.5%
3.78
US$54,868 		14,500 +10.5% 3.78 US$54,868
2024-09-12 2024-09-12 PrS Proposed sale
3.4
Mark Austin

affiliate
2,500
15.80
US$39,500 		2,500 15.80 US$39,500
2024-06-18 2024-06-17 B Purchase
3.7
Hunt Jonathan Robert

Chief Financial Officer

Officer
1,800 +5.3%
9.82
US$17,667 		1,800 +5.3% 9.82 US$17,667
2024-06-18 2024-06-14 B Purchase
4.0
Woods Lori A
Non-Executive Director
83 +0.1%
10.80
US$896 		83 +0.1% 10.80 US$896
2024-06-18 2024-06-14 B Purchase
4.0
Woods Lori A
Non-Executive Director
4,504 +2.9%
10.90
US$49,094 		4,504 +2.9% 10.90 US$49,094
2024-06-13 2024-06-13 B Purchase
3.6
Spoor Johan M.

CEO

Executive Director
100,000 +266.2%
1.17
US$117,430 		100,000 +266.2% 1.17 US$117,430
2024-06-04 2024-06-03 B Purchase
4.0
Woods Lori A
Non-Executive Director
34,246 +2.3%
1.46
US$49,992 		34,246 +2.3% 1.46 US$49,992
2024-06-03 2024-05-31 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
55,000 +14.9%
1.38
US$75,900 		55,000 +14.9% 1.38 US$75,900
2024-06-03 2024-05-31 B Purchase
3.7
Hunt Jonathan Robert

Chief Financial Officer

Officer
12,000 +3.6%
1.40
US$16,800 		12,000 +3.6% 1.40 US$16,800
2024-06-03 2024-05-31 B Purchase
3.7
Hunt Jonathan Robert

Chief Financial Officer

Officer
13,006 +4.1%
1.40
US$18,207 		13,006 +4.1% 1.40 US$18,207
2024-05-30 2024-05-29 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
18,656 +5.3%
1.34
US$24,999 		18,656 +5.3% 1.34 US$24,999
2024-05-30 2024-05-29 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
11,375 +3.4%
1.32
US$15,015 		11,375 +3.4% 1.32 US$15,015
2024-03-08 2024-03-06 B Purchase
Lantheus Alpha Therapy, LLC
Large shareholder
60,431,039 +107.3%
0.95
US$57,409,487 		60,431,039 +107.3% 0.95 US$57,409,487
2024-02-01 2024-01-30 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
3,500 +1.0%
0.70
US$2,450 		3,500 +1.0% 0.70 US$2,450
2024-02-01 2024-01-30 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
42,879 +14.7%
0.72
US$30,873 		42,879 +14.7% 0.72 US$30,873
2024-02-01 2024-01-30 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
57,121 +24.3%
0.71
US$40,556 		57,121 +24.3% 0.71 US$40,556
2024-02-01 2024-01-30 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
5,127 +2.2%
0.71
US$3,640 		5,127 +2.2% 0.71 US$3,640
2024-02-01 2024-01-30 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
18,579 +8.8%
0.71
US$13,191 		18,579 +8.8% 0.71 US$13,191
2024-01-30 2024-01-29 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
21,235 +11.2%
0.64
US$13,590 		21,235 +11.2% 0.64 US$13,590
2024-01-30 2024-01-29 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
4,031 +2.2%
0.64
US$2,580 		4,031 +2.2% 0.64 US$2,580
2024-01-30 2024-01-26 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
50,000 +36.7%
0.54
US$27,000 		50,000 +36.7% 0.54 US$27,000
2024-01-30 2024-01-26 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
25,000 +22.5%
0.55
US$13,750 		25,000 +22.5% 0.55 US$13,750
2024-01-30 2024-01-26 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
8,513 +8.3%
0.59
US$5,023 		8,513 +8.3% 0.59 US$5,023
2024-01-30 2024-01-26 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
14,850 +16.9%
0.61
US$9,058 		14,850 +16.9% 0.61 US$9,058
2024-01-30 2024-01-26 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
12,250 +16.2%
0.61
US$7,472 		12,250 +16.2% 0.61 US$7,472
2024-01-26 2024-01-25 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
22,134 +41.3%
0.49
US$10,846 		22,134 +41.3% 0.49 US$10,846
2024-01-26 2024-01-24 B Purchase
3.8
Puhlmann Markus

Chief Medical Officer

Officer
280,000 +25.6%
0.50
US$139,888 		280,000 +25.6% 0.50 US$139,888
2024-01-26 2024-01-24 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
29,862 +126.1%
0.49
US$14,632 		29,862 +126.1% 0.49 US$14,632
2023-12-26 2023-12-21 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
3,663 +inf%
0.33
US$1,203 		3,663 +inf% 0.33 US$1,203
2023-12-19 2023-12-19 B Purchase
3.8
Puhlmann Markus

Chief Medical Officer

Officer
400,000 +57.5%
0.34
US$137,000 		400,000 +57.5% 0.34 US$137,000
2023-12-19 2023-12-19 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
13,680 +136.8%
0.32
US$4,378 		13,680 +136.8% 0.32 US$4,378
2023-12-19 2023-12-18 B Purchase
3.8
Puhlmann Markus

Chief Medical Officer

Officer
60,419 +9.5%
0.26
US$15,461 		60,419 +9.5% 0.26 US$15,461
2023-12-19 2023-12-18 B Purchase
4.1
Williamson Robert F III
Non-Executive Director
10,000 +inf%
0.26
US$2,600 		10,000 +inf% 0.26 US$2,600
2023-12-19 2023-12-18 B Purchase
3.7
Hunt Jonathan Robert

Chief Financial Officer

Officer
125,000 +65.2%
0.26
US$32,338 		125,000 +65.2% 0.26 US$32,338
2023-12-19 2023-12-15 B Purchase
3.8
Puhlmann Markus

Chief Medical Officer

Officer
135,006 +27.0%
0.27
US$36,276 		135,006 +27.0% 0.27 US$36,276
2023-12-18 2023-12-15 B Purchase
4.0
Woods Lori A
Non-Executive Director
152,962 +11.2%
0.27
US$41,284 		152,962 +11.2% 0.27 US$41,284
2023-12-18 2023-12-14 B Purchase
4.0
Woods Lori A
Non-Executive Director
32,238 +2.4%
0.27
US$8,704 		32,238 +2.4% 0.27 US$8,704
2022-12-05 2022-12-05 B Purchase
3.7
Hunt Jonathan Robert

Chief Financial Officer

Officer
32,200 +20.2%
0.38
US$12,236 		32,200 +20.2% 0.38 US$12,236
2022-12-05 2022-12-01 B Purchase
3.7
Hunt Jonathan Robert

Chief Financial Officer

Officer
53,204 +50.0%
0.38
US$20,265 		53,204 +50.0% 0.38 US$20,265
2022-11-17 2022-11-15 B Purchase
4.0
Woods Lori A

CEO

Executive Director
100,000 +9.6%
0.34
US$33,540 		100,000 +9.6% 0.34 US$33,540
2022-06-09 2022-06-09 B Purchase
3.4
Austin Mark John

VP Finance/Prin Fin&Acct Offic

Officer
13,800 +34.3%
0.29
US$3,959 		13,800 +34.3% 0.29 US$3,959
2022-06-09 2022-06-08 B Purchase
3.4
Austin Mark John

VP Finance/Prin Fin&Acct Offic

Officer
5,000 +14.2%
0.29
US$1,425 		5,000 +14.2% 0.29 US$1,425
2022-06-09 2022-06-08 B Purchase
3.7
Hunt Jonathan Robert

Chief Financial Officer

Officer
25,675 +31.8%
0.29
US$7,443 		25,675 +31.8% 0.29 US$7,443
2022-06-09 2022-06-07 B Purchase
4.0
Woods Lori A

CEO

Executive Director
75,000 +7.7%
0.30
US$22,230 		75,000 +7.7% 0.30 US$22,230
2022-06-09 2022-06-07 B Purchase
3.7
Hunt Jonathan Robert

Chief Financial Officer

Officer
13,325 +19.8%
0.28
US$3,718 		13,325 +19.8% 0.28 US$3,718
2020-12-02 2020-11-30 B Purchase
4.0
Woods Lori A

CEO

Executive Director
68,000 +12.5%
0.38
US$25,534 		68,000 +12.5% 0.38 US$25,534
2020-10-28 2020-10-22 B Purchase
3.7
Hunt Jonathan Robert

Chief Financial Officer

Officer
67,306 +inf%
0.52
US$34,999 		67,306 +inf% 0.52 US$34,999
2020-10-28 2020-10-22 B Purchase
McCormick Michael W
Non-Executive Director
19,230 +87.4%
0.52
US$10,000 		19,230 +87.4% 0.52 US$10,000
2020-10-28 2020-10-22 B Purchase
4.0
Woods Lori A

CEO

Executive Director
48,076 +inf%
0.52
US$25,000 		48,076 +inf% 0.52 US$25,000
2020-10-28 2020-10-22 B Purchase
Cavanagh William

Chief R&D Officer

Officer
7,692 +38.5%
0.52
US$4,000 		7,692 +38.5% 0.52 US$4,000
2020-10-28 2020-10-22 B Purchase
Hoffmann Alan
Non-Executive Director
19,230 +inf%
0.52
US$10,000 		19,230 +inf% 0.52 US$10,000
2020-10-28 2020-10-22 B Purchase
3.4
Austin Mark John

Controller/Prin Fin&Acct Offic

Officer
19,230 +120.2%
0.52
US$10,000 		19,230 +120.2% 0.52 US$10,000
2020-10-28 2020-10-22 B Purchase
Vitale Philip J
Non-Executive Director
20,000 +18.2%
0.52
US$10,400 		20,000 +18.2% 0.52 US$10,400
2020-10-28 2020-10-22 B Purchase
Krachon Michael

EVP of Sales & Marketing

Officer
28,844 +52.4%
0.52
US$14,999 		28,844 +52.4% 0.52 US$14,999
2019-11-21 2019-11-20 B Purchase Krachon Michael

VP of Sales & Marketing

Officer
50,000 +inf%
0.39
US$19,495 		50,000 +inf% 0.39 US$19,495
2019-11-19 2019-11-15 B Purchase Cavanagh William

Chief R&D Officer

Officer
10,000 +100.0%
0.39
US$3,900 		10,000 +100.0% 0.39 US$3,900
2019-11-19 2019-11-15 B Purchase Woods Lori A

CEO

Executive Director
25,000 +9.8%
0.39
US$9,745 		25,000 +9.8% 0.39 US$9,745
Explore more

More insider trading research around Perspective Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America